Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.680
+0.180 (12.00%)
At close: Feb 25, 2026, 4:00 PM EST
1.710
+0.030 (1.79%)
After-hours: Feb 25, 2026, 7:59 PM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $53.01 million as of February 25, 2026. Its market cap has decreased by -71.72% in one year.
Market Cap
53.01M
Enterprise Value
-77.67M
1-Year Change
-71.72%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $53.01M, a decrease of -77.45%. That is a compound annual growth rate of -36.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 47.33M | -37.76% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 52.11M |
| Estrella Immunopharma | 50.65M |
| NeurAxis | 50.60M |
| Kezar Life Sciences | 49.43M |
| Plus Therapeutics | 48.12M |
| Impact BioMedical | 46.22M |
| Apollomics | 45.29M |
| NextCure | 45.01M |